Prothena to Present at the 2015 Credit Suisse Healthcare Conference on November 10
DUBLIN, Nov. 04, 2015 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today announced that members of the senior management team will present and participate in the 2015 Credit Suisse Healthcare Conference on November 10th at 6:00 PM ET at The Phoenician Hotel in Scottsdale, AZ.
A live webcast of the presentation can be accessed through the investor relations section of the Company`s website at www.prothena.com. Following the live presentation, replays of the webcasts will be available on the Company`s website for at least 90 days following the presentation date.
About Prothena
Prothena Corporation plc is a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapy programs for the potential treatment of diseases that involve amyloid or cell adhesion. The company is developing antibody-based product candidates that target a number of potential indications including AL amyloidosis (NEOD001), Parkinson`s disease and other related synucleinopathies (PRX002), and psoriasis and other inflammatory diseases (PRX003).
For more information, please visit the company`s web site at www.prothena.com.
Investors: Tran Nguyen, CFO
650-837-8535, IR@prothena.com
Media: Ellen Rose
650-922-2405, ellen.rose@prothena.com
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Prothena Corporation plc via GlobeNewswire
HUG#1961821
